correct me if I am wrong, but the debate which started at about and around [1] didn't quite finish.
Would you trust the output of this chip, as it has been presented/used in the paper [2]?
1.Katsanis, S.H., Javitt, G. & Hudson, K. A Case Study of Personalized Medicine. Science 320, 53 -54 (2008).
2.Konstantinopoulos, P.A. et al. Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer. PLoS ONE 6, e18202 (2011).
My robotics training hardly qualifies me to asses the output of their academic research. However, I applaud their commitment to publishing results it top-tier academic journals.
Off-handed comments (in a thread about Google) calling 23andMe's scientific research "misleading" seems a bit snarky. Educated discussion has a place -- eg. in HN threads related to the company [1] or (especially) in the peer-review process.
Would you trust the output of this chip, as it has been presented/used in the paper [2]?
1.Katsanis, S.H., Javitt, G. & Hudson, K. A Case Study of Personalized Medicine. Science 320, 53 -54 (2008).
2.Konstantinopoulos, P.A. et al. Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer. PLoS ONE 6, e18202 (2011).